Revolution Medicines commercialization chief Anthony Mancini sells $743,436 in common shares
RVMD•Chief Global Commercialization Officer Anthony Mancini reported selling 3,708 Revolution Medicines shares on Sept. 24-25, 2026, for a total of $743,436.
1. Share transactions
Mancini sold 587 shares at $200 each on Sept. 24 and 3,121 shares at $200.54 each on Sept. 25. He also exercised options for 3,121 shares at $33.62 on Sept. 25. He directly held 39,765 common shares after the transactions.
